Last 12 months
Inside the activity.
2 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2020 Filed Mar 5, 2020 17:31 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
Exercise / conversionCommon Stock | 463 | $20.60 | $9,537.80 |
DisclosureSEC source: 0001214659-20-002275 · marketforms-48148.xml · nonDerivative · entry 1 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,077.768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Represents 17,202.498 vested restricted stock units and 3,875.270 shares of Common Stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:34 UTC |
Carley Donald MGeneral Counsel
|
GrantCommon Stock | 2,275 | $39.45 | $89,751.94 |
DisclosureSEC source: 0001214659-20-002136 · marketforms-48060.xml · nonDerivative · entry 1 Carley Donald M · CIK 0001665149 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,863.844 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.16 to $39.50. F2 · balance_after: Represents 9,615.844 vested restricted stock units and 3,248 shares of Common Stock. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 19:24 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $45.59 | $159,573.75 |
DisclosureSEC source: 0001214659-20-001128 · marketforms-47708.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,069.099 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.47 to $45.95. F3 · balance_after: Represents 56,845.099 vested restricted stock units and 35,224 shares of Common Stock. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:04 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $44.13 | $154,469.00 |
DisclosureSEC source: 0001214659-20-000213 · marketforms-47387.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,569.099 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.91 to $44.26. F3 · balance_after: Represents 56,845.099 vested restricted stock units and 38,724 shares of Common Stock. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 21:35 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 450 | $43.77 | $19,696.50 |
DisclosureSEC source: 0001214659-20-000042 · marketforms-47058.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,689.523 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2019. F2 · balance_after: Represents 10,891.523 vested restricted stock units and 5,798 shares of Common Stock. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 21:59 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $44.67 | $156,339.05 |
DisclosureSEC source: 0001214659-19-007652 · marketforms-46830.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,434.347 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.20 to $44.89. F3 · balance_after: Represents 49,210.347 vested restricted stock units and 42,224 shares of Common Stock. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 22:21 UTC |
Robinson AllanExecutive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,744 | $0.00 Strike: $31.01 | $0.00 |
DisclosureSEC source: 0001214659-19-007585 · marketforms-46788.xml · derivative · entry 5 Robinson Allan · CIK 0001707915 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 6,744 shares Expires 2026-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 22:21 UTC |
Robinson AllanExecutive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,908 | $0.00 Strike: $33.41 | $0.00 |
DisclosureSEC source: 0001214659-19-007585 · marketforms-46788.xml · derivative · entry 4 Robinson Allan · CIK 0001707915 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,908 shares Expires 2025-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 22:21 UTC |
Robinson AllanExecutive Vice President
|
SaleCommon Stock | 10,652 | $43.31 | $461,353.03 |
DisclosureSEC source: 0001214659-19-007585 · marketforms-46788.xml · nonDerivative · entry 3 Robinson Allan · CIK 0001707915 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,889.136 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.17 to $43.43. F4 · balance_after: Represents 22.136 vested restricted stock units and 6,867 shares of Common Stock. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 22:21 UTC |
Robinson AllanExecutive Vice President
|
Exercise / conversionCommon Stock | 6,744 | $31.01 | $209,131.44 |
DisclosureSEC source: 0001214659-19-007585 · marketforms-46788.xml · nonDerivative · entry 2 Robinson Allan · CIK 0001707915 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,541.136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Represents 22.136 vested restricted stock units and 17,519 shares of Common Stock. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 22:21 UTC |
Robinson AllanExecutive Vice President
|
Exercise / conversionCommon Stock | 3,908 | $33.41 | $130,566.28 |
DisclosureSEC source: 0001214659-19-007585 · marketforms-46788.xml · nonDerivative · entry 1 Robinson Allan · CIK 0001707915 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,797.136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Represents 22.136 vested restricted stock units and 10,775 shares of Common Stock. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 20:20 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $43.99 | $153,972.00 |
DisclosureSEC source: 0001214659-19-006936 · marketforms-46067.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,934.347 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.67 to $44.15. F3 · balance_after: Represents 49,210.347 vested restricted stock units and 45,724 shares of Common Stock. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:07 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $45.30 | $158,555.95 |
DisclosureSEC source: 0001214659-19-006310 · marketforms-45942.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,434.347 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.15 to $45.65. F3 · balance_after: Represents 49,210.347 vested restricted stock units and 49,224 shares of Common Stock. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:06 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 450 | $45.46 | $20,457.00 |
DisclosureSEC source: 0001214659-19-006309 · marketforms-45941.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,139.523 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2019. F2 · balance_after: Represents 10,891.523 vested restricted stock units and 6,248 shares of Common Stock. Read SEC document |
| September 18, 2019 Filed Sep 19, 2019 21:33 UTC |
CONKLIN BRET AEVP & CFO
|
SaleCommon Stock | 833 | $46.13 | $38,423.54 |
DisclosureSEC source: 0001214659-19-005955 · marketforms-45792.xml · nonDerivative · entry 3 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,999.205 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.11 to $46.14. F5 · balance_after: Represents 30,117.693 vested restricted stock units, 9,493.570 deferred restricted stock units and 6,387.972 shares of Common Stock. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 21:33 UTC |
CONKLIN BRET AEVP & CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,552 | $0.00 Strike: $20.60 | $0.00 |
DisclosureSEC source: 0001214659-19-005955 · marketforms-45792.xml · derivative · entry 5 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,552 shares Expires 2020-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 21:33 UTC |
CONKLIN BRET AEVP & CFO
|
SaleCommon Stock | 10,175 | $46.22 | $470,320.04 |
DisclosureSEC source: 0001214659-19-005955 · marketforms-45792.xml · nonDerivative · entry 2 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,832.205 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.15 to $46.26. F3 · balance_after: Represents 30,117.663 vested restricted stock units, 9,493.570 deferred restricted stock units and 7,220.972 shares of Common Stock. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 21:33 UTC |
CONKLIN BRET AEVP & CFO
|
Exercise / conversionCommon Stock | 5,552 | $20.60 | $114,371.20 |
DisclosureSEC source: 0001214659-19-005955 · marketforms-45792.xml · nonDerivative · entry 1 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,007.205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Represents 30,117.663 vested restricted stock units, 9,493.570 deferred restricted stock units and 17,395.972 shares of Common Stock. Read SEC document |
| September 13, 2019 Filed Sep 16, 2019 19:06 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 828 | $48.03 | $39,765.94 |
DisclosureSEC source: 0001214659-19-005876 · marketforms-45780.xml · nonDerivative · entry 2 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,593.299 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 28, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.14. F5 · balance_after: Represents 172,307.299 vested restricted stock units and 62,286 shares of Common Stock. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 19:06 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 3,431 | $48.02 | $164,765.88 |
DisclosureSEC source: 0001214659-19-005876 · marketforms-45780.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,421.299 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 28, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.08. F3 · balance_after: Represents 172,307.299 vested restricted stock units and 63,114 shares of Common Stock. Read SEC document |
| September 11, 2019 Filed Sep 13, 2019 15:28 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 14,000 | $47.06 | $658,882.00 |
DisclosureSEC source: 0001214659-19-005845 · marketforms-45767.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,852.299 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 28, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.17. F3 · balance_after: Represents 172,307.299 vested restricted stock units and 66,545 shares of Common Stock. Read SEC document |
| September 10, 2019 Filed Sep 11, 2019 19:26 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 8,994 | $46.10 | $414,589.22 |
DisclosureSEC source: 0001214659-19-005820 · marketforms-45758.xml · nonDerivative · entry 2 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,852.299 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 28, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.28. F5 · balance_after: Represents 172,307.299 vested restricted stock units and 80,545 shares of Common Stock. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 19:26 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 5,006 | $46.01 | $230,333.57 |
DisclosureSEC source: 0001214659-19-005820 · marketforms-45758.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,846.299 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 28, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.08. F3 · balance_after: Represents 172,307.299 vested restricted stock units and 89,539 shares of Common Stock. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 20:25 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $45.19 | $158,173.40 |
DisclosureSEC source: 0001214659-19-005811 · marketforms-45747.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,630.858 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.53 to $45.36. F3 · balance_after: Represents 48,906.858 vested restricted stock units and 52,724 shares of Common Stock. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:55 UTC |
Stricker RobertDirector
|
SaleCommon Stock | 157 | $44.65 | $7,010.05 |
DisclosureSEC source: 0001214659-19-005734 · marketforms-45710.xml · nonDerivative · entry 1 Stricker Robert · CIK 0001478287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,082.816 F1 · balance_after: Represents 12,914.770 vested share-based restricted stock units, 10,606.829 deferred cash restricted stock units and 9,849 shares of Common Stock. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 23:54 UTC |
Stricker RobertDirector
|
SaleCommon Stock | 3,843 | $44.20 | $169,873.67 |
DisclosureSEC source: 0001214659-19-005405 · marketforms-45528.xml · nonDerivative · entry 1 Stricker Robert · CIK 0001478287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,239.816 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.11 to $44.36. F2 · balance_after: Represents 12,914.770 vested share-based restricted stock units, 10,606.829 deferred cash restricted stock units and 10,006 shares of Common Stock. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:19 UTC |
JOHNSON KIMBERLY AVice President & Controller
|
SaleCommon Stock | 1,500 | $44.32 | $66,474.15 |
DisclosureSEC source: 0001214659-19-005315 · marketforms-45496.xml · nonDerivative · entry 1 JOHNSON KIMBERLY A · CIK 0001708307 · Vice President & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,429.574 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.75 to $44.45. F2 · balance_after: Represents 16,026.437 vested restricted stock units and 3,403.137 shares of Common Stock. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 19:55 UTC |
Rugenstein WadeExecutive Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 17,592 | $0.00 Strike: $42.73 | $0.00 |
DisclosureSEC source: 0001214659-19-004968 · marketforms-45415.xml · derivative · entry 2 Rugenstein Wade · CIK 0001782331 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,592 shares Expires 2029-08-01 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on August 1, 2020. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 19:55 UTC |
Rugenstein WadeExecutive Vice President
|
GrantCommon Stock | 1,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-004968 · marketforms-45415.xml · nonDerivative · entry 1 Rugenstein Wade · CIK 0001782331 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning August 1, 2020. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 19:57 UTC |
Rugenstein WadeExecutive Vice President
|
GrantCommon Stock | 7,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-004635 · marketforms-45322.xml · nonDerivative · entry 1 Rugenstein Wade · CIK 0001782331 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will fully vest on July 12, 2022. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 16:44 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 400 | $40.44 | $16,176.00 |
DisclosureSEC source: 0001214659-19-004060 · marketforms-45175.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,259.44 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 26, 2018. F2 · balance_after: Represents 12,154.440 vested restricted stock units and 3,105 shares of Common Stock. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:40 UTC |
Hines Perry G.Director
|
GrantCommon Stock | 2,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-003808 · marketforms-45056.xml · nonDerivative · entry 1 Hines Perry G. · CIK 0001741555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 22, 2020. F2 · price: Granted as compensation for services. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:45 UTC |
Swyers Steven O.Director
|
GrantCommon Stock | 2,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-003813 · marketforms-45059.xml · nonDerivative · entry 1 Swyers Steven O. · CIK 0001608926 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,154.339 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 22, 2020. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 12,154.339 vested share-based restricted stock units. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:43 UTC |
Reece Henry WadeDirector
|
GrantCommon Stock | 3,059.976 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-003811 · marketforms-45060.xml · nonDerivative · entry 2 Reece Henry Wade · CIK 0001675638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,769.202 F4 · security: The acquisition of Common Stock reported hereby is in the form of deferred cash restricted stock units pursuant to the 2010 Comprehensive Executive Compensation Plan as amended and restated. F2 · price: Granted as compensation for services. F5 · balance_after: Represents 5,709.226 vested share-based restricted stock units and 3,059.976 deferred cash restricted stock units. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:43 UTC |
Reece Henry WadeDirector
|
GrantCommon Stock | 2,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-003811 · marketforms-45060.xml · nonDerivative · entry 1 Reece Henry Wade · CIK 0001675638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,709.226 F1 · security: The acquisition of Common Stock reported hereby is in the form of share-based restricted stock units which will vest in full on May 22, 2020. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 5,709.226 vested share-based restricted stock units. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:44 UTC |
Stricker RobertDirector
|
GrantCommon Stock | 2,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-003812 · marketforms-45058.xml · nonDerivative · entry 1 Stricker Robert · CIK 0001478287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,016.943 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 22, 2020. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 12,823.266 vested share-based restricted stock units, 10,531.677 deferred cash restricted stock units and 11,662 shares of common stock. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:41 UTC |
KONEN MARK EDirector
|
GrantCommon Stock | 2,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-003809 · marketforms-45054.xml · nonDerivative · entry 1 KONEN MARK E · CIK 0001280429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 22, 2020. F2 · price: Granted as compensation for services. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:42 UTC |
McClure Beverley J.Director
|
GrantCommon Stock | 2,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-003810 · marketforms-45057.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,659.44 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 22, 2020. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 12,154.440 vested restricted stock units and 3,505 shares of common stock. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:39 UTC |
Hassenmiller SteveDirector
|
GrantCommon Stock | 2,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-003807 · marketforms-45055.xml · nonDerivative · entry 1 Hassenmiller Steve · CIK 0001303207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,664 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 22, 2020. F2 · price: Granted as compensation for services. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:38 UTC |
Domenech Daniel ADirector
|
GrantCommon Stock | 2,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-003806 · marketforms-45050.xml · nonDerivative · entry 1 Domenech Daniel A · CIK 0001642977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,286.914 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 22, 2020. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 8,561.321 vested share-based restricted stock units and 6,725.593 deferred cash restricted stock units. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:36 UTC |
Casady Mark SDirector
|
GrantCommon Stock | 2,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-003805 · marketforms-45052.xml · nonDerivative · entry 1 Casady Mark S · CIK 0001405275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 22, 2020. F2 · price: Granted as compensation for services. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 19:28 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 400 | $35.41 | $14,164.00 |
DisclosureSEC source: 0001214659-19-002543 · marketforms-44754.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,659.44 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 26, 2018. F2 · balance_after: Represents 12,154.440 vested restricted stock units and 3,505 shares of Common Stock. Read SEC document |
| March 21, 2019 Filed Mar 25, 2019 19:48 UTC |
CONKLIN BRET AEVP & CFO
|
SaleCommon Stock | 6,466 | $35.99 | $232,740.44 |
DisclosureSEC source: 0001214659-19-002257 · marketforms-44667.xml · nonDerivative · entry 1 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,690.071 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.71 to $36.31. F2 · balance_after: Represents 29,560.167 vested share-based restricted stock units, 9,349.961 deferred cash restricted stock units and 11,779.943 shares of Common Stock. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:01 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,444 | $0.00 Strike: $38.99 | $0.00 |
DisclosureSEC source: 0001214659-19-001946 · marketforms-44503.xml · derivative · entry 3 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,444 shares Expires 2029-03-05 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 5, 2020. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:01 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantCommon Stock | 8,379.02 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-001946 · marketforms-44503.xml · nonDerivative · entry 2 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,753.469 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 56,291.469 vested restricted stock units and 35,462 shares of Common Stock. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:01 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantCommon Stock | 2,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-001946 · marketforms-44503.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,374.449 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 5, 2020. F2 · balance_after: Represents 47,912.449 vested restricted stock units and 35,462 shares of Common Stock. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 21:48 UTC |
CONKLIN BRET AEVP & CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,488 | $0.00 Strike: $17.32 | $0.00 |
DisclosureSEC source: 0001214659-19-001940 · marketforms-44498.xml · derivative · entry 7 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,488 shares Expires 2019-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 21:48 UTC |
CONKLIN BRET AEVP & CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,636 | $0.00 Strike: $38.99 | $0.00 |
DisclosureSEC source: 0001214659-19-001940 · marketforms-44498.xml · derivative · entry 6 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,636 shares Expires 2029-03-05 F8 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 5, 2020. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 21:48 UTC |
CONKLIN BRET AEVP & CFO
|
SaleCommon Stock | 3,443 | $39.09 | $134,586.87 |
DisclosureSEC source: 0001214659-19-001940 · marketforms-44498.xml · nonDerivative · entry 4 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,288.374 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.35. F7 · balance_after: Represents 32,495.368 restricted stock units, 9,349.961 deferred restricted stock units and 8,443.045 shares of Common Stock. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 21:48 UTC |
CONKLIN BRET AEVP & CFO
|
Exercise / conversionCommon Stock | 7,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-001940 · marketforms-44498.xml · nonDerivative · entry 3 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,731.374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · balance_after: Represents 32,495.368 vested restricted stock units, 9,349.961 deferred restricted stock units and 11,886.045 shares of Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.